Theoretical impact of a mobile team dedicated to patients with Alzheimer's disease and related dementias on medication exposure in community-dwelling older patients (MEMORIAS study).

Emotional disturbances during pregnancy, including antenatal depression and anxiety, are increasingly recognized as significant public health concerns due to their impact on maternal well-being and child development. Antenatal depression is among the leading causes of disability in pregnant women globally, especially in low-income settings. Although prevalence rates vary between countries, antenatal depression is generally more common than postpartum depression. Globally, approximately 15.6% of women experience prenatal depression. Depressive symptoms can occur throughout pregnancy, although published studies have reported variable prevalence across trimesters without a clearly consistent temporal pattern. Meta-analytical data show that depression affects 7.4% of women in the first trimester, 12.8% in the second, and 12% in the third. Clinical depression is diagnosed in 10–20% of pregnant women, while over a quarter report depressive symptoms. In the Arab world, the prevalence of maternal depression ranges between 10% and 37%. Among Gulf countries, the highest rate is reported in Bahrain (37%); followed by the UAE (10–20%), Kuwait (11.7%); and Qatar (17.6%). In Oman, antenatal depression is increasingly observed in both clinical practice and community-based research. One national study found that 12% of pregnant women were at risk of postnatal depression, while another reported a 24.3% prevalence of antenatal depression among 959 pregnant women higher than rates in several neighboring countries.